Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Das

Showing results (481-490 of 75,378) with videos related to

Pageof 7,538
Sort By:
Indian Journal of Medical Sciences|October 7, 2009
Group-A beta-hemolytic streptococci resistance pattern in north Indian pediatric populationSrijit Das
The Lancet. Oncology|May 17, 2017
Brigatinib effective in ALK-positive non-small-cell lung cancerManjulika Das
The Lancet. Oncology|June 20, 2017
Adjuvant pertuzumab improves early breast cancer outcomesManjulika Das
Medical Physics|November 26, 2009
A role for biological optimization within the current treatment planning paradigmShiva Das
The Lancet. Oncology|June 13, 2017
Olaparib provides benefit in metastatic breast cancerManjulika Das
The Lancet. Oncology|May 10, 2017
Neoadjuvant chemotherapy: survival benefit in gastric cancerManjulika Das
The Lancet. Oncology|April 11, 2018
Health care for cancer survivors in the USAManjulika Das
The Lancet. Oncology|July 4, 2017
Midostaurin in FLT3-mutated acute myeloid leukaemiaManjulika Das
The Lancet. Oncology|June 26, 2018
Urologists reduce overtreatment in prostate cancerManjulika Das
BMJ (Clinical Research Ed.)|July 8, 2018
Prejudice persists against black and ethnic minority doctorsPartha Das
Pageof 7,538

Showing results (481-490 of 75,378) with videos related to

Sort By:
Pageof 7,538
Indian Journal of Medical Sciences|October 7, 2009
Group-A beta-hemolytic streptococci resistance pattern in north Indian pediatric populationSrijit Das
The Lancet. Oncology|May 17, 2017
Brigatinib effective in ALK-positive non-small-cell lung cancerManjulika Das
The Lancet. Oncology|June 20, 2017
Adjuvant pertuzumab improves early breast cancer outcomesManjulika Das
Medical Physics|November 26, 2009
A role for biological optimization within the current treatment planning paradigmShiva Das
The Lancet. Oncology|June 13, 2017
Olaparib provides benefit in metastatic breast cancerManjulika Das
The Lancet. Oncology|May 10, 2017
Neoadjuvant chemotherapy: survival benefit in gastric cancerManjulika Das
The Lancet. Oncology|April 11, 2018
Health care for cancer survivors in the USAManjulika Das
The Lancet. Oncology|July 4, 2017
Midostaurin in FLT3-mutated acute myeloid leukaemiaManjulika Das
The Lancet. Oncology|June 26, 2018
Urologists reduce overtreatment in prostate cancerManjulika Das
BMJ (Clinical Research Ed.)|July 8, 2018
Prejudice persists against black and ethnic minority doctorsPartha Das
Pageof 7,538